Halozyme Therapeutics HALO Intangible assets — net
Intangible assets — net at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's intangible assets — net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's intangible assets — net?
- Halozyme Therapeutics (HALO) reported intangible assets — net of $951.96M in Q1 2026.
- How has Halozyme Therapeutics's intangible assets — net changed year-over-year?
- Halozyme Therapeutics's intangible assets — net increased by 183.9% year-over-year, from $335.37M to $951.96M.